I think that's the case with Vertex. Here are seven reasons why Vertex is a no-brainer stock to buy on the dip.

After the FDA's landmark approval of the opioid-free acute pain reliever Journavx in January, Vertex Pharmaceuticals has hit ...

Vertex stock falls after pain drug VX-993 fails Phase 2 trial, despite better-than-expected Q2 earnings and strong cystic ...

Vertex Pharmaceuticals will stop developing its experimental non-opioid painkiller as a solo treatment after a mid-stage ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $481.56, ...

Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to provide post-surgery benefits and US regulators ...

Vertex Pharmaceuticals Inc.’s bad news from a phase II pain study and separately on the regulatory front caused shares ...

Minecraft's latest update adds a ton of fixes and new features via Bedrock 1.21.100, which appears on consoles as version ...

Minecraft's latest major update is now available for download that adds new features, a slate of bug fixes via version 3.17 ...

Looking to beef up your Wi-Fi network? A wireless range extender is a less expensive alternative to a new router. (Some can even turn your router setup into a mesh system.) Here are the top ...

Treatment with the selective NaV1.8 pain signal inhibitor VX-993 after bunionectomy surgery did not meet the primary endpoint -- ...